Monday 16 November 2026
Export KYNB’s income statement to Excel — free account
Kyntra Bio Inc
KYNBKyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.
- Revenue
- n/m
- EPS
- n/m
- Free cash flow
- n/m
Quarter to June 2026, against a year earlier
3.44
0.15
−4.18%
Follow KYNB
Alert me
What it owns vs. what it owes End of fiscal 2025, 31 December 2025
Debt has fallen from $97.4M to $71.9M since FY16. Liabilities are $17.0M more than assets: shareholders’ equity is negative. What is a balance sheet?
Owns
$361.0KLong-term assets
$10.1MOther short-term assets
$109.1MCash & all investments
Funded by
$136.6MOther liabilities
Debt is 0.0% of the total; liabilities are $17.0M more than assets.
Net cash fell from 48% of assets to 32% since FY16.
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | $0.5B | $0.9B | $0.9B | $0.9B | $0.8B | $0.8B | $0.6B | $0.4B |
| Net debt (debt less cash) | −$0.2B | −$0.6B | −$0.6B | −$0.6B | −$0.7B | −$0.5B | −$0.3B | −$0.1B |
| Net debt ÷ assets (right axis) | −48.3% | −72.2% | −64.6% | −65.0% | −80.3% | −60.8% | −54.9% | −32.3% |
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
88.98 | 50.48 | 203.45 | 422.01 | 405.19 | 686.54 | 533.76 | 621.40 | 735.72 | 253.18 |
Receivables |
0.22 | 0.48 | 5.12 | 16.30 | 17.40 | 41.88 | 28.46 | 63.68 | 8.45 | 10.45 |
Inventory |
3.74 | 3.16 | 17.17 | 40.44 | 31.02 | 16.53 | 6.89 | — | — | — |
Other current assets |
— | 110.85 | 65.78 | 14.08 | 12.45 | 10.16 | 8.18 | 4.93 | 4.80 | 2.89 |
Total current assets |
99.07 | 196.51 | 331.56 | 492.83 | 474.06 | 755.11 | 702.49 | 690.02 | 748.97 | 266.52 |
Property, Plant, Equpment (Net) |
— | — | 4.79 | 20.61 | 28.28 | 33.65 | 42.74 | 127.20 | 129.48 | 123.66 |
Long-Term Investments |
20.16 | — | 5.29 | 9.41 | 171.62 | 2.97 | 61.12 | 55.82 | 10.51 | 71.01 |
Long-term assets (Other) |
0.36 | 18.02 | 22.25 | 7.35 | 8.75 | 3.46 | 11.44 | 7.57 | 9.70 | 8.37 |
Total non-current assets |
20.52 | 18.02 | 91.97 | 117.26 | 299.76 | 71.73 | 154.91 | 190.58 | 149.68 | 203.04 |
Total Assets |
119.59 | 214.53 | 423.53 | 610.09 | 773.82 | 826.84 | 857.40 | 880.60 | 898.65 | 469.55 |
Accounts Payable |
3.75 | 5.06 | 15.78 | 30.76 | 26.10 | 24.79 | 6.09 | 9.14 | 5.51 | 6.22 |
Accrued Expenses |
20.18 | 62.04 | 132.99 | 219.77 | 172.60 | 118.33 | 83.82 | 66.12 | 63.78 | 50.91 |
Current Part of Capital Lease |
— | — | — | — | 0.01 | 12.33 | 12.35 | — | — | — |
Current Revenue (Deferred) |
5.31 | 27.29 | 12.74 | 12.74 | 15.86 | 6.55 | 0.49 | 13.77 | 16.67 | 7.99 |
Other current liabilities |
— | 38.92 | 43.52 | 232.48 | 188.45 | 124.88 | 83.32 | 79.89 | 80.45 | 58.90 |
Total current liabilities |
29.24 | 133.31 | 217.67 | 273.56 | 225.50 | 163.19 | 102.75 | 89.03 | 85.96 | 65.13 |
Long Term Debt (Total) |
— | 73.09 | 71.93 | 96.65 | 106.39 | 25.39 | 37.61 | 107.96 | 97.76 | 97.35 |
Non-current Revenue (Deferred) |
0.26 | 114.71 | 157.56 | 185.72 | 186.80 | 138.47 | 99.45 | 139.15 | 141.90 | 110.92 |
Minority Interests |
21.48 | 21.48 | 21.48 | — | — | — | — | — | — | — |
Non-current Liabilities (Other) |
85.62 | 77.05 | 73.54 | 72.69 | 43.63 | 57.49 | 82.19 | 26.79 | 25.29 | 21.05 |
Total non-current liabilities |
107.36 | 286.33 | 389.54 | 338.01 | 319.21 | 222.20 | 219.25 | 263.10 | 264.95 | 229.32 |
Total liabilities |
136.60 | 419.64 | 607.21 | 611.57 | 544.71 | 385.39 | 321.99 | 352.13 | 350.91 | 294.44 |
Additional Paid In Capital |
1,677.18 | 1,668.62 | 1,643.64 | 1,541.02 | 1,476.41 | 1,399.77 | 1,300.73 | 1,226.45 | 1,160.09 | 625.90 |
Common Stock (Net) |
1.01 | 1.01 | 0.99 | 0.94 | 0.93 | 0.91 | 0.88 | 0.85 | 0.83 | 0.64 |
Retained Earnings |
(1,706.05) | (1,889.50) | (1,841.92) | (1,557.69) | (1,264.03) | (974.01) | (784.72) | (715.83) | (630.66) | (469.74) |
Common Equity (Total) |
(17.01) | (205.11) | (183.68) | (1.48) | 229.11 | 441.45 | 535.41 | 528.47 | 547.74 | 175.11 |
Shareholders Equity (Total) |
(17.00) | (205.11) | (183.68) | (1.48) | 229.11 | 441.45 | 535.41 | 528.47 | 547.74 | 175.11 |
Shareholders Equity and Liabilities (Total) |
119.59 | 214.53 | 423.53 | 610.09 | 773.82 | 826.84 | 857.40 | 880.60 | 898.65 | 469.55 |
Shares (Common) |
4.05 | 4.04 | 3.95 | 3.77 | 3.72 | 3.66 | 3.51 | 3.42 | 3.30 | 2.55 |
Shareholders Equity (Tangible) |
(17.00) | (205.11) | (183.68) | (1.48) | 229.11 | 441.45 | 535.41 | 528.47 | 547.74 | 175.11 |
Net Debt |
(88.98) | 22.61 | (131.52) | (325.36) | (298.80) | (661.15) | (496.15) | (513.45) | (637.95) | (155.83) |
Total Debt |
— | 73.09 | 71.93 | 96.65 | 106.39 | 25.39 | 37.61 | 107.96 | 97.76 | 97.35 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026